SciClone regulatory update

SciClone Pharmaceuticals Inc. (SCLN) SCLN's lead drug, Zadaxin thymosin alpha 1, received marketing approval in Singapore for treatment of chronic hepatitis B. SCLN expects marketing to begin during...